MS Patients on Cladribine Show Fewer Relapses

(MedPage Today) -- Patients with multiple sclerosis (MS) treated with cladribine tablets (Mavenclad) were less likely to experience disease relapse than those who were treated with other oral disease-modifying therapies, real-world data from the...